# A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure

> **NCT00487799** · PHASE1 · WITHDRAWN · sponsor: **Facet Biotech** · enrollment: 32 (estimated)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** Ularitide

## Key facts

- **NCT ID:** NCT00487799
- **Lead sponsor:** Facet Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 32 (ESTIMATED)
- **Why stopped:** Facet no longer has ownership of ularitide.
- **Last updated:** 2009-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487799, "A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00487799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*